This week, the Food and Drug Administration finally gave their full approval to the COVID-19 vaccine from Pfizer and BioNTech.
Millions of doses had already been administered under an emergency use authorization, or EUA. It’s a slightly lower regulatory bar meant for public health crises.
Dr. Colleen Kelley, an infectious diseases researcher at Emory University, says the vaccine getting full approval is a big deal. She joined WABE’s “All Things Considered” and started by laying out how FDA approval differs from EUA.
